BioSpace News Archive

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of software and software-enabled services for the financial services and healthcare industries, today announced that Rahul Kanwar, President and Chief Operating Officer, will present at the RBC Capital Markets Financial Technology Virtual Conference

- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that Cancer and Hematology Centers of Western Michigan (CHCWM) has adopted Precipio’s HemeScreen technology to launch molecular testing assay for hematologic malignancies such as myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). As part of Precipio’s recently launched Reagent Rental program, CHCWM’s laboratory is in the process of validati

FDA-cleared iHEARtest™ now available free of charge to mitigate impact of COVID-19 pandemic

ARUP Laboratories, a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI)-based image analysis solutions for the diagnostics industry, published a study in the Journal of Clinical Microbiology on their groundbreaking AI-augmented ova and parasite detection tool.

The Pulmonary Fibrosis Foundation (PFF) today announced the appointment of three highly respected pulmonologists as senior members of its medical team.

Enhanced Collaboration will Address Disparities in Health Care Access Through Shared Education, Research and Clinical Goals [09-June-2020] DETROIT , June 9, 2020 /PRNewswire/ -- Henry Ford Health System and Michigan State University (MSU) announced today the two organizations have signed a letter of intent (LOI) to significantly expand their long-term partnership, a

La Jolla Vein Care (LJVC), a leader in vein treatment serving the Southern California community for more than a decade, is actively working to enhance its traditional service offerings to assist new and existing clients amid the unprecedented times brought forth by COVID-19.

IsoPlexis secures grant funding to expand Alzheimer’s applications using functional single-cell proteomics on the IsoLight system

CURE Pharmaceutical Holding Corp. (OTC: CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients, announced today that it strengthened its balance sheet with the receipt of $1.4 million in cash from the exercise of warrants to purchase 708,467 shares of CURE’s common stock held by certain stockholders of Chemistry Holdings, Inc. (Chemistry Holdings) at a reduced exercise price of $2.00 per share (

4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design that utilizes its proprietary Truss Implant Technology™, announced today that the company has received 510(k)